Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Takeda discovers new Taxol-like compound

Oct. 31, 1997

HMR discloses azasteroids for estrogen/androgen-mediated disorders

Oct. 31, 1997

IntraBiotics codevelops IB-367 with Pharmacia & Upjohn

Oct. 31, 1997

Angiogenesis-inhibitory peptides available for licensing from NIH

Oct. 31, 1997

BE-52440A and BE-52440B: novel antitumor antibiotics reported in patent literature

Oct. 31, 1997

Inflammatory and angiogenic protein-related technology available for licensing

Oct. 30, 1997

Neovascularization inhibitors disclosed by Takeda

Oct. 30, 1997

Bicalutamide + LHRH-A vs. flutamide + LHRH-A for metastatic prostate cancer

Oct. 29, 1997

Banyu discloses protein farnesyltransferase inhibitors

Oct. 29, 1997

Biomeasure discloses protein farnesyltranserase inhibitors

Oct. 29, 1997

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
Japan endorses two iPSC drugs for approval under CEA pathway
BioWorld
Japan is backing conditional approvals of Amchepry (raguneprocel, Sumitomo Pharma Co. Ltd./Racthera Co. Ltd.) and Reheart (Cuorips Inc.), positioning them to...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 24, 2026
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...